Author

Rolf Malessa

Observed names: R Malessa, R. MALESSA, R. Malessa, R. Maleßa

Institution: Sophien-und Hufeland Klinikum

Observed institutions: Goethe University Frankfurt, University of Cologne, University of Colorado Health, Essen University Hospital, University Hospital Frankfurt, Jena University Hospital, Sophien-und Hufeland Klinikum, Deutsches Diabetes-Zentrum e.V., University Hospital Cologne, Heinrich Heine University Düsseldorf, University of Duisburg-Essen, Friedrich Schiller University Jena, University of Colorado Denver

OpenAlex ID: A5010652194

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

1999 · D Ziegler, M Hanefeld, et al. · Diabetes Care · 433

Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate

2001 · Marcus W. Agelink, Rolf Malessa, et al. · Clinical Autonomic Research · 351

Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis

1995 · Wolfgang Liedtke, Rolf Malessa, et al. · Journal of NeuroVirology · 77

The Goltz–Ferrier debates and the triumph of cerebral localizationalist theory

2000 · Kenneth L. Tyler, Rolf Malessa · Neurology · 68

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS)

2007 · Volker Limmroth, Rolf Malessa, et al. · Journal of Neurology · 61

Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis

1993 · U R Hengge, N H Brockmeyer, et al. · Antimicrobial Agents and Chemotherapy · 60

Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials

2021 · Igor Dykukha, Rolf Malessa, et al. · Pain Medicine · 55

Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN)

1998 · M.W Agelink, R Malessa, et al. · Journal of the Neurological Sciences · 51

Cardiovascular Autonomic Reactivity in Schizophrenics under Neuroleptic Treatment: A Potential Predictor of Short-Term Outcome?

1998 · M.W. Agelink, R. Malessa, et al. · Neuropsychobiology · 33

A functional-structural model to understand cardiac autonomic nervous system (ANS) dysregulation in affective illness and to elucidate the ANS effects of antidepressive treatment.

2004 · Marcus W Agelink, A Klimke, et al. · PubMed · 25

Dysfunction of visual pathways in HIV-1 infection

1995 · Rolf Malessa, Marcus W. Agelink, et al. · Journal of the Neurological Sciences · 23

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

2018 · Maria Trojano, Helmut Butzkueven, et al. · Multiple Sclerosis and Related Disorders · 19

PDF

Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy

1996 · Rolf Malessa, Maja Heimbach, et al. · Journal of the Neurological Sciences · 19

Improved Autonomic Neurocardial Balance in Short-term Abstinent Alcoholics Treated With Acamprosate

1998 · M. W. AGELINK, W. LEMMER, et al. · Alcohol and Alcoholism · 17

Evozierte Potentiale bei neurologisch asymptomatischen Personen in frühen Stadien der HIV-Infektion

1989 · R. Maleßa, M. Heuser-Link, et al. · Klinische Neurophysiologie · 16

Hirnmetabolische Veränderungen bei chronischem Rückenschmerz

2016 · L. Janetzki, A. Gussew, et al. · Der Schmerz · 13

ANTI-Rh(D) IMMUNOGLOBULIN FOR AIDS-RELATED THROMBOCYTOPENIA

1986 · R. Biniek, R. Malessa, et al. · The Lancet · 12

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

2010 · R. Malessa, A. Gendolla, et al. · Current Medical Research and Opinion · 10

Sensitivity of Carbohydrate-deficient Transferrin (cdt) in Relation to Age and Duration of Abstinence

1998 · M. W. AGELINK, A. DIRKES-KERSTING, et al. · Alcohol and Alcoholism · 10

Nutzen und Risiken der Elektrokrampfbehandlung (EKT) bei älteren Patienten mit kardiovaskulären Risikofaktoren

1998 · M. W. Agelink, S. Dammers, et al. · Der Nervenarzt · 10

Disseminated cerebral hemorrhages as unusual manifestation of toxoplasmic encephalitis in AIDS

1996 · Peter Berlit, Octavian Popescu, et al. · Journal of the Neurological Sciences · 10

Nerve conduction changes in asymptomatic HIV-1 seropositive individuals in the absence of other risk factors for neuropathy.

1996 · R Malessa, M Agelink, et al. · PubMed · 9

Vaskuläre Demenz im Wandel - eine Übersicht zur vaskulären Demenz von zurückliegenden zu neuen Konzepten

1994 · Th. Kloß, R. Maleßa, et al. · Fortschritte der Neurologie · Psychiatrie · 9

Oligosymptomatic neurosyphilis with false negative CSF-VDRL in HIV-infected individuals?

1996 · R Malessa, M W Agelink, et al. · PubMed · 8

[Discordant syringomyelia twins in familial syringomyelia].

1986 · R Malessa, J Jörg · PubMed · 8

Works count: 60

Citation count: 1,455

H-index: 15

I10-index: 21